Literature DB >> 19796997

Rationale for reversal of failed bariatric operations.

Robert E Brolin1, Muhammad Asad.   

Abstract

BACKGROUND: No guidelines are available to assist surgeons in determining whether reversal is appropriate for patients with problematic bariatric operations.
METHODS: A retrospective review of 2573 primary and 252 revisional bariatric operations was performed to determine the indications for the reversal of problematic bariatric operations.
RESULTS: Of the 82 patients who had undergone reoperation for complications of the primary operation, 13 had undergone reversal rather than revision. Reversal was performed at the patient's request for 5 patients with intractable vomiting after banded restrictive operations and 2 patients with intractable diarrhea after jejunoileal bypass. The surgeon recommended reversal for the remaining 6 patients, including 3 with active substance abuse and 3 with severe metabolic complications. One postoperative complication (wound infection) occurred, with no deaths.
CONCLUSION: The decision to reverse, rather than revise, a problematic bariatric operation is motivated by the perspective that the outcome of revision would also be problematic. Improved patient education and follow-up by the primary surgeon might have obviated the need for reversal in about one half of the patients in the present series.

Entities:  

Mesh:

Year:  2009        PMID: 19796997     DOI: 10.1016/j.soard.2009.08.002

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  7 in total

1.  Reasons and operative outcomes after reversal of gastric bypass and jejunoileal bypass.

Authors:  Elias Chousleb; Sheetal Patel; Samuel Szomstein; Raul Rosenthal
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

2.  Management of Excessive Weight Loss Following Laparoscopic Roux-en-Y Gastric Bypass: Clinical Algorithm and Surgical Techniques.

Authors:  Ikemefuna Akusoba; T Javier Birriel; Maher El Chaar
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

3.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

4.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

5.  Laparoscopic reversal of Roux-en-Y gastric bypass into normal anatomy with or without sleeve gastrectomy.

Authors:  Ramon Vilallonga; Simon van de Vrande; Jacques Himpens
Journal:  Surg Endosc       Date:  2013-07-17       Impact factor: 4.584

Review 6.  The economic impact of weight regain.

Authors:  Caroline E Sheppard; Erica L W Lester; Anderson W Chuck; Daniel W Birch; Shahzeer Karmali; Christopher J de Gara
Journal:  Gastroenterol Res Pract       Date:  2013-12-26       Impact factor: 2.260

7.  A Protocol for Rehabilitating the Bypassed Limb Prior to Reversal of Jejunoileal Bypass.

Authors:  Sara Santini; Michel Suter; Maude Martinho-Grueber; Carole Monney Chaubert; Mohammed Barigou; Lucie Favre; Peter Kopp; Anne Kouadio
Journal:  Obes Surg       Date:  2021-02-06       Impact factor: 4.129

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.